Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110 and are disrupted in oncogenic p85 mutants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110 and are disrupted in oncogenic p85 mutants

Published:2009-11-13 Issue:48 Volume:106 Page:20258-20263
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Wu H.,Shekar S. C.,Flinn R. J.,El-Sibai M.,Jaiswal B. S.,Sen K. I.,Janakiraman V.,Seshagiri S.,Gerfen G. J.,Girvin M. E.,Backer J. M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference45 articles.

1. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

2. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells

3. Synthesis and Function of 3-Phosphorylated Inositol Lipids

4. The activation of phosphatidylinositol 3-kinase by Ras

5. Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications;Seminars in Cancer Biology;2024-11

2. Tumor antigen presentation and the associated signal transduction during carcinogenesis;Pathology - Research and Practice;2024-09

3. Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells;Cellular Signalling;2024-09

4. Chemotherapy-induced high expression of IL23A enhances efficacy of anti-PD-1 therapy in TNBC by co-activating the PI3K-AKT signaling pathway of CTLs;Scientific Reports;2024-06-20

5. A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism;Cell Reports;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3